Immunotoxicity studies of trans-resveratrol in male B6C3F1/N mice
Madelyn C. Huang, Kimber L. White Jr., Susan A. Elmore, Tai L. Guo, Dori Germolec
DOI:
https://doi.org/10.22427/NTP-DATA-002-02772-0033-0000-6
Publication
Abstract
Resveratrol is a naturally-occurring polyphenol that is being investigated to treat and prevent various diseases, both experimentally and in the clinic. Despite increased use and interest in resveratrol due to its immunomodulatory properties, there is a lack of studies evaluating potential toxicities associated with resveratrol use, particularly immunotoxicity. A previous 2-week study found decreasing thymus weight in male B6C3F1/N mice with increasing exposure to trans-resveratrol. This study is a follow-up on those findings, specifically evaluating immune function. Male adult B6C3F1/N mice were given trans-resveratrol (0, 156, 312, 625, 1250, 2500 mg/kg/day) via oral gavage for 28 days and functional immune tests and histopathology were evaluated. There were no treatment-related effects on body weight during the study. Humoral, cell-mediated, and innate immune function were not altered after 28 days of trans-resveratrol treatment. There were also no changes in organ weight or microscopic alterations in immune organs. Overall, under the conditions of this study, there was no evidence of immunotoxicity or improvements in immune function associated with oral exposure to trans-resveratrol in male mice. Importantly, the immunomodulatory benefits of resveratrol may require a pre-requisite level of inflammatory activity and may not be observable in healthy individuals.
Immunotoxicology
Study Tables
- I01 - Animal Removal Summary (118 KB)
- I02 - Animal Removals (1 MB)
- I03C - Growth Curve (2 MB)
- I04 - Mean Body Weight Summary (401 KB)
- I04G - Mean Body Weight Gain (372 KB)
- M07 - TDAR SRBC Spleen AFC (65 KB)
- M08 - Serum IgM Antibody Titers to T - Dependent Antigen Sheep Erythrocytes (31 KB)
- M09 - Serum Antibody Concentrations for the T - Dependent Keyhole Limpet Hemocyanin (32 KB)
- M11 - Spleen Cell Proliferative Response to Anti - CD3 Stimulation (32 KB)
- M12 - Cytotoxic T Cell Axtivity (44 KB)
- M14V - Mononuclear Phagocytic System Summary (57 KB)
- M15 - Natural Killer Cell Activity (43 KB)
- M20V - Mixed Leukocyte Response Summary (34 KB)
- P03 - Incidence Rates of Non-Neoplastic Lesions by Anatomic Site (19 KB)
- P09 - Non-Neoplastic Lesions by Individual Animal (121 KB)
- PA06 - Organ Weights Summary (208 KB)
Individual Animal Data
- Individual Animal ANTI-CD3 Proliferation Data (14 KB)
- Individual Animal Body Weight Data (89 KB)
- Individual Animal Gross Observations Data (56 KB)
- Individual Animal In Vitro Cytotoxic T Lymphocyte Data (17 KB)
- Individual Animal Mixed Leukocyte Response Data (14 KB)
- Individual Animal Mononuclear Phagocytic System Data (16 KB)
- Individual Animal Natural Killer Cell Activity Data (17 KB)
- Individual Animal Organ Weight Data (35 KB)
- Individual Animal Periodic Weight Gain Data (78 KB)
- Individual Animal Serum Anti-KLH ELISA Data (7 KB)
- Individual Animal Serum IgM Data (16 KB)
- Individual Animal Survival Data (10 KB)
- Individual Animal T-Dependent Antibody Response Data (20 KB)
- Individual Animal Terminal Body Weight Data (17 KB)